Crisaborole 2% ointment as an effective and safe option in mild to moderate atopic dermatitis: data from a pilot study

Crisaborole might emerge as a potential long-term therapeutic option in not only paediatric patients, but also adult patients with mild to moderate atopic dermatitis. Our pilot study, carried out on a cohort of Indian patients, emphasizes the safety, reliability and efficacy of this novel molecule on atopic dermatitis.